This examination of prescription drug expenditures and the usage of formularies in managing drug utilization is divided into two main sections. First, the prescription drug industry is studied for reasons why drug costs are increasingly so dramatically in recent years. Statistics are given to explain why there should be a concern in our society about this trend, and the therapeutic classes are identified to show where the most money is being spent. The following possible reasons for increasing drug expenditures are discussed: increasing prices, product shift, higher utilization, patents, research costs, decreasing out of pocket expenses, our aging society, and direct-to-consumer advertising.In the second section of this paper, a definition ...
The questions asked in this thesis relate to the economic incentives and characteristics of the heal...
Thesis advisor: Julie H. MortimerThe unifying theme of this dissertation is the growing importance o...
Provides a detailed assessment of the formularies, drug costs, and utilization management tools offe...
The healthcare costs in the United States are growing at an alarming rate. With the costs expected t...
The U.S. pharmaceutical industry has been remarkably successful in developing new treatments for man...
Thesis (Ph.D.)--University of Washington, 2020Background: Value-based formularies (VBF) are a way to...
ormularies have existed in various forms for nearly 100 years.1 Beginning as a simple list of availa...
Actuary at Milliman USA in Indianapolis, IN. Curtis Gary Dean was his honors thesis advisor. In the ...
Prescription drug expenditures have risen considerably over the last decade and employers have incre...
Prescription drug expenditures make up less than 10 percent of total personal health care expenditur...
Thesis (Ph.D.)--University of Washington, 2015The standard economic model for health insurance posit...
Outlines various options for addressing prescription drug spending growth, including a description o...
Consumers do not purchase prescription drugs in a standard marketplace setting; instead, they rely o...
Controlling the cost of prescription drugs is integral to improving health outcomes, and patient acc...
In the United States, high prices of prescription drugs and rapidly increasing prescription drug spe...
The questions asked in this thesis relate to the economic incentives and characteristics of the heal...
Thesis advisor: Julie H. MortimerThe unifying theme of this dissertation is the growing importance o...
Provides a detailed assessment of the formularies, drug costs, and utilization management tools offe...
The healthcare costs in the United States are growing at an alarming rate. With the costs expected t...
The U.S. pharmaceutical industry has been remarkably successful in developing new treatments for man...
Thesis (Ph.D.)--University of Washington, 2020Background: Value-based formularies (VBF) are a way to...
ormularies have existed in various forms for nearly 100 years.1 Beginning as a simple list of availa...
Actuary at Milliman USA in Indianapolis, IN. Curtis Gary Dean was his honors thesis advisor. In the ...
Prescription drug expenditures have risen considerably over the last decade and employers have incre...
Prescription drug expenditures make up less than 10 percent of total personal health care expenditur...
Thesis (Ph.D.)--University of Washington, 2015The standard economic model for health insurance posit...
Outlines various options for addressing prescription drug spending growth, including a description o...
Consumers do not purchase prescription drugs in a standard marketplace setting; instead, they rely o...
Controlling the cost of prescription drugs is integral to improving health outcomes, and patient acc...
In the United States, high prices of prescription drugs and rapidly increasing prescription drug spe...
The questions asked in this thesis relate to the economic incentives and characteristics of the heal...
Thesis advisor: Julie H. MortimerThe unifying theme of this dissertation is the growing importance o...
Provides a detailed assessment of the formularies, drug costs, and utilization management tools offe...